On the public citation graph

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021

https://doi.org/10.1093/ofid/ofac044
0 signed · 64 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamainternmed.2020.4130openalex-snapshot
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
inferredcites →https://doi.org/10.1001/jamapediatrics.2020.1948openalex-snapshot
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
inferredcites →https://doi.org/10.1038/s41467-020-18450-4openalex-snapshot
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
inferredcites →https://doi.org/10.1038/s41467-021-27595-9openalex-snapshot
Robust and durable serological response following pediatric SARS-CoV-2 infection
inferredcites →https://doi.org/10.1038/s41591-020-0897-1openalex-snapshot
Antibody responses to SARS-CoV-2 in patients with COVID-19
inferredcites →https://doi.org/10.1038/s41591-020-0962-9openalex-snapshot
Age-dependent effects in the transmission and control of COVID-19 epidemics
inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
inferredcites →https://doi.org/10.1056/nejmc2013020openalex-snapshot
Natural History of Asymptomatic SARS-CoV-2 Infection
inferredcites →https://doi.org/10.1093/cid/ciaa1785openalex-snapshot
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020
inferredcites →https://doi.org/10.1093/cid/ciaa1804openalex-snapshot
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey
inferredcites →https://doi.org/10.1093/cid/ciaa955openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study
inferredcites →https://doi.org/10.1093/cid/ciab185openalex-snapshot
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March–August, 2020
inferredcites →https://doi.org/10.1093/infdis/jiab296openalex-snapshot
Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June–October 2020: A Population-Based Survey
inferredcites →https://doi.org/10.1093/ofid/ofab379openalex-snapshot
SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California
inferredcites →https://doi.org/10.1101/2021.04.27.21256207openalex-snapshot
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
inferredcites →https://doi.org/10.1126/sciadv.abh3409openalex-snapshot
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
inferredcites →https://doi.org/10.1542/peds.2020-027425openalex-snapshot
National Trends of Cases of COVID-19 in Children Based on US State Health Department Data
inferredcites →https://doi.org/10.1542/peds.2020-031682openalex-snapshot
The Challenge of Clearly Counting COVID-19 Cases in Children
inferredcites →https://doi.org/10.1542/peds.2020-031971openalex-snapshot
COVID-19 Transmission in US Child Care Programs
inferredcites →https://doi.org/10.1542/peds.2020-0702openalex-snapshot
Epidemiology of COVID-19 Among Children in China
inferredcites →https://doi.org/10.1542/peds.2020-0834openalex-snapshot
COVID-19 in Children: Initial Characterization of the Pediatric Disease
inferredcites →https://doi.org/10.1542/peds.2021-052589openalex-snapshot
Duration of Effective Antibody Levels After COVID-19
inferredcites →https://doi.org/10.15585/mmwr.mm6934e2openalex-snapshot
Limited Secondary Transmission of SARS-CoV-2 in Child Care Programs — Rhode Island, June 1–July 31, 2020
inferredcites →https://doi.org/10.15585/mmwr.mm6947a2openalex-snapshot
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020
inferredcites →https://doi.org/10.15585/mmwr.mm6949e1openalex-snapshot
The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
inferredcites →https://doi.org/10.15585/mmwr.mm695152e2openalex-snapshot
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7004e3openalex-snapshot
COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7011a2openalex-snapshot
Minimal SARS-CoV-2 Transmission After Implementation of a Comprehensive Mitigation Strategy at a School — New Jersey, August 20–November 27, 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7012e3openalex-snapshot
Low SARS-CoV-2 Transmission in Elementary Schools — Salt Lake County, Utah, December 3, 2020–January 31, 2021
inferredcites →https://doi.org/10.15585/mmwr.mm7012e4openalex-snapshot
Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies — St. Louis County and City of Springfield, Missouri, December 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7020a3openalex-snapshot
Characteristics of COVID-19 Cases and Outbreaks at Child Care Facilities — District of Columbia, July–December 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7020e1openalex-snapshot
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
inferredcites →https://doi.org/10.15585/mmwr.mm7021e1openalex-snapshot
Mask Use and Ventilation Improvements to Reduce COVID-19 Incidence in Elementary Schools — Georgia, November 16–December 11, 2020
inferredcites →https://doi.org/10.15585/mmwr.mm7023e1openalex-snapshot
Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021
inferredcites →https://doi.org/10.15585/mmwr.mm7030e2openalex-snapshot
Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
inferredcites →https://doi.org/10.15585/mmwr.mm7036e2openalex-snapshot
Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021
inferredcites →https://doi.org/10.15585/mmwr.mm7045e1openalex-snapshot
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
inferredcites →https://doi.org/10.3201/eid2607.200841openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4092074openalex-extracted
Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Estimation Using Commercial Laboratory Specimens: How Representative Is It of the General U.S. Pediatric Population?
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.23253openalex-snapshot
Post–COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1002/ccr3.70119openalex-snapshot
Post‐COVID Hypertension With Hyperreninemic Hyperaldosteronism in a Pediatric Patient
inferred← citeshttps://doi.org/10.1007/s00285-023-01948-yopenalex-snapshot
Analysis of metapopulation models of the transmission of SARS-CoV-2 in the United States
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2023.110630openalex-snapshot
SARS-CoV-2 serology in pediatrics: Seroprevalence studies in unvaccinated children and humoral antibody response post vaccination
inferred← citeshttps://doi.org/10.1016/j.jtbi.2026.112531openalex-snapshot
A comparison of alternative vaccination strategies for protecting those vulnerable to illness, hospitalization, or death upon infection with SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.lana.2022.100403openalex-snapshot
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
inferred← citeshttps://doi.org/10.1017/s0950268823000481openalex-snapshot
Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina
inferred← citeshttps://doi.org/10.1038/s43856-023-00376-9openalex-snapshot
Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia
inferred← citeshttps://doi.org/10.1093/infdis/jiac423openalex-snapshot
Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care—September 2021 to February 2022
inferred← citeshttps://doi.org/10.1093/ofid/ofac246openalex-snapshot
CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021
inferred← citeshttps://doi.org/10.1093/ofid/ofac507openalex-snapshot
Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Before Coronavirus Disease 2019 Vaccination Among Children 0–4 Years and Their Household Members in the SEARCh Study
inferred← citeshttps://doi.org/10.1093/ofid/ofae680openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence and Associated Risk Factors in a Large Cohort of US Children
inferred← citeshttps://doi.org/10.1093/ofid/ofae719openalex-snapshot
Ratio of Infections to COVID-19 Cases and Hospitalizations in the United States based on SARS-CoV-2 Seroprevalence Data, September 2021–February 2022
inferred← citeshttps://doi.org/10.1111/irv.13094openalex-snapshot
National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan
inferred← citeshttps://doi.org/10.1128/spectrum.00691-24openalex-snapshot
School mask policies and SARS-CoV-2 seroprevalence among school-age children—United States, September to December 2021
inferred← citeshttps://doi.org/10.1371/journal.pone.0284046openalex-snapshot
A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study
inferred← citeshttps://doi.org/10.1542/pedsos.2024-000264openalex-snapshot
Pediatric SARS-CoV-2 Incidence in California by Vaccination Status, December 2021 to April 2023
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4203020/v1openalex-snapshot
Neurological manifestations of acute SARS-CoV-2 infection in pediatric patients: a 3-year study
inferred← citeshttps://doi.org/10.3201/eid2905.221541openalex-snapshot
SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021
inferred← citeshttps://doi.org/10.3390/covid5050068openalex-snapshot
At-Home Testing to Characterize SARS-CoV-2 Seroprevalence Among Children and Adolescents
inferred← citeshttps://doi.org/10.3390/pathogens12111360openalex-snapshot
The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance
inferred← citeshttps://doi.org/10.3390/v16060967openalex-snapshot
Neurological Manifestations of Acute SARS-CoV-2 Infection in Pediatric Patients: A 3-Year Study on Differences between Pandemic Waves
inferred← citeshttps://doi.org/10.3390/vaccines11061024openalex-snapshot
Epidemiology and SARS-CoV-2 Infection Patterns among Youth Followed at a Large Los Angeles Health Network during 2020–2022: Clinical Presentation, Prevalent Strains, and Correlates of Disease Severity
inferred← citeshttps://doi.org/10.34172/aim.2023.100openalex-snapshot
Clinical Manifestations Laboratory Tests Abdominal Ultrasonic Findings and In-hospital Prognosis of COVID-19 in 185 Pediatric Cases in a Tertiary Center
inferred← citeshttps://doi.org/10.5001/omj.2022.75openalex-snapshot
Vaccinating our Children and Adolescents Against COVID-19
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.